HRS4800
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
April 08, 2022
A Study to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.
(clinicaltrials.gov)
- P2a | N=38 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P2a trial • Pain
March 31, 2022
A Trial of HRS4800 Tables in Healthy Male Subjects
(clinicaltrials.gov)
- P1 | N=40 | Completed | Sponsor: Atridia Pty Ltd. | Recruiting ➔ Completed
Trial completion • Pain
August 31, 2021
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects
(clinicaltrials.gov)
- P1; N=96; Enrolling by invitation; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Not yet recruiting ➔ Enrolling by invitation
Clinical • Enrollment open • Pain
August 18, 2021
A Trial of HRS4800 Tables in Healthy Male Subjects
(clinicaltrials.gov)
- P1; N=50; Recruiting; Sponsor: Atridia Pty Ltd.; Trial primary completion date: Feb 2021 ➔ Dec 2021
Clinical • Trial primary completion date • Pain
August 05, 2021
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects
(clinicaltrials.gov)
- P1; N=96; Not yet recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P1 trial • Pain
April 28, 2021
A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects
(clinicaltrials.gov)
- P1; N=50; Not yet recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Clinical • New P1 trial • Pain
February 04, 2021
A Trial of HRS4800 Tables in Healthy Male Subjects
(clinicaltrials.gov)
- P1; N=50; Recruiting; Sponsor: Atridia Pty Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Pain
October 02, 2020
A Trial of HRS4800 Tables in Healthy Male Subjects
(clinicaltrials.gov)
- P1; N=50; Not yet recruiting; Sponsor: Atridia Pty Ltd.
Clinical • New P1 trial • Pain
1 to 8
Of
8
Go to page
1